Halcinonide is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

• The topical cream, ointment, or solution should be applied sparingly to the affected area once or twice daily, as directed by the healthcare provider.
• The frequency of application may be adjusted based on the severity of the condition.

Side effects associated with Halcinonide include-

• Common Adverse Reactions:
  • Burning or stinging sensation upon application.
  • Itching or irritation at the site of application.
• Less Common Adverse Reactions:
  • Dryness or peeling of the skin.
  • Hypopigmentation or hyperpigmentation.
  • Folliculitis or acneiform eruptions.

Burning sensation

Irritation

Dry skin

Peeling

• Superinfection: Topical corticosteroids may promote the growth of non-susceptible organisms. If signs of secondary infection occur, discontinue use.
• Use in Pregnancy: Halcinonide should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
• Systemic Absorption: Prolonged use or use over large areas may result in systemic absorption, leading to systemic effects. Use caution, especially in pediatric patients.
• Ocular Effects: Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
• Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitaryadrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some patients.